The Division includes Principal Laboratory Investigators, whose areas of interest include: Angiogenesis control and regulation; apoptosis; cellular adhesion; cytokine expression and regulation; virally-mediated immuno-modulatory gene therapy, and and pancreatic and melanoma cancer biology.
Each investigator maintains an active research laboratory interacting with colleagues within the institution and with extramural collaborators. They have successfully competed for grant support from Federal and other granting agencies.
The Division works to translate basic science research directly to the care of patients. These efforts involve close collaborations between clinicians and laboratory-based researchers. Current translational projects include initiatives in breast cancer, bladder cancer, prostate cancer, melanoma, pancreas cancer, and colorectal cancer.